Genç Huntington Hastalığında Güncel Farmakolojik Yönetim.

Araştırma özeti

Aşağıdaki metin kaynak makalenin lisansı doğrulanmış orijinal özetidir. cc by

BackgroundThe clinical presentation of Juvenile Huntington's Disease (JHD) can be very different from adult-onset HD with little evidence to guide symptomatic management.AimTo survey the current use of pharmacological treatments for JHD.MethodsPatients were identified through the HD Association, Hospital Doctors and the European Huntington's Disease Network REGISTRY study.ResultsThe most commonly prescribed agents were anti-psychotics (24/45), anti-depressants (17/45) and anti-parkinsonian medications (15/45). 5 patients were taking more than 8 medications.ConclusionsThe most commonly prescribed group of medication was the anti-psychotic. Many patients were on multiple therapies, highlighting the need to rationalise medications.

İlgili konular